XML 27 R20.htm IDEA: XBRL DOCUMENT v3.24.2.u1
FAIR VALUE MEASUREMENTS (Tables)
6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Schedule of cash equivalents, restricted cash and marketable securities by security type

Cash equivalents, restricted cash and marketable securities by security type at June 30, 2024 were as follows:

 

 

 

 

 

 

Gross

 

 

Gross

 

 

 

 

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Estimated

 

(In thousands)

 

Cost

 

 

Gains

 

 

Losses

 

 

Fair Value

 

Included in cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

74,801

 

 

$

 

 

$

 

 

$

74,801

 

 

 

$

74,801

 

 

$

 

 

$

 

 

$

74,801

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted cash:

 

 

 

 

 

 

 

 

 

 

 

 

Money market fund

 

$

850

 

 

$

 

 

$

 

 

$

850

 

Certificate of deposit

 

 

273

 

 

 

 

 

 

 

 

 

273

 

 

$

1,123

 

 

$

 

 

$

 

 

$

1,123

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities (due in
   less than one year)

 

$

39,885

 

 

$

 

 

$

(30

)

 

$

39,855

 

Government-sponsored enterprise
   securities (due in less than one year)

 

 

44,532

 

 

 

2

 

 

 

(44

)

 

 

44,490

 

Government-sponsored enterprise securities
   (due in one to two years)

 

 

5,000

 

 

 

 

 

 

(9

)

 

 

4,991

 

Commercial paper (due in less than
   one year)

 

 

110,400

 

 

 

1

 

 

 

(192

)

 

 

110,209

 

Corporate notes (due in less than one year)

 

 

51,347

 

 

 

3

 

 

 

(115

)

 

 

51,235

 

Corporate notes (due in one to two years)

 

 

61,630

 

 

 

5

 

 

 

(121

)

 

 

61,514

 

 

 

$

312,794

 

 

$

11

 

 

$

(511

)

 

$

312,294

 

 

Cash equivalents, restricted cash and marketable securities by security type at December 31, 2023 were as follows:

 

 

 

 

 

Gross

 

 

Gross

 

 

 

 

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Estimated

 

(In thousands)

 

Cost

 

 

Gains

 

 

Losses

 

 

Fair Value

 

Included in cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

16,815

 

 

$

 

 

$

 

 

$

16,815

 

 

 

$

16,815

 

 

$

 

 

$

 

 

$

16,815

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted cash:

 

 

 

 

 

 

 

 

 

 

 

 

Money market fund

 

$

843

 

 

$

 

 

$

 

 

$

843

 

Certificate of deposit

 

 

272

 

 

 

 

 

 

 

 

 

272

 

 

$

1,115

 

 

$

 

 

$

 

 

$

1,115

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities (due in
   less than one year)

 

$

26,752

 

 

$

95

 

 

$

 

 

$

26,847

 

U.S. Treasury securities (due in
 one to two years)

 

 

2,877

 

 

 

17

 

 

 

 

 

 

2,894

 

Government-sponsored enterprise securities
   (due in less than one year)

 

 

86,250

 

 

 

43

 

 

 

(92

)

 

 

86,201

 

Government-sponsored enterprise securities
   (due in one to two years)

 

 

13,598

 

 

 

72

 

 

 

 

 

 

13,670

 

Commercial paper (due in less than
   one year)

 

 

102,270

 

 

 

31

 

 

 

(33

)

 

 

102,268

 

Corporate notes (due in less than one year)

 

 

48,409

 

 

 

14

 

 

 

(63

)

 

 

48,360

 

Corporate notes (due in one to two years)

 

 

26,628

 

 

 

130

 

 

 

(24

)

 

 

26,734

 

 

 

$

306,784

 

 

$

402

 

 

$

(212

)

 

$

306,974

 

 

Schedule of cash equivalents and marketable securities with unrealized losses

Cash equivalents and marketable securities with unrealized losses that have been in a continuous unrealized loss position for less than 12 months and 12 months or longer at June 30, 2024 and December 31, 2023 were as follows:

 

 

 

Less Than 12 Months

 

 

12 Months or Longer

 

 

Total

 

 

 

 

 

 

Gross

 

 

 

 

 

Gross

 

 

 

 

 

Gross

 

 

 

Estimated

 

 

Unrealized

 

 

Estimated

 

 

Unrealized

 

 

Estimated

 

 

Unrealized

 

(In thousands)

 

Fair Value

 

 

Losses

 

 

Fair Value

 

 

Losses

 

 

Fair Value

 

 

Losses

 

As of June 30, 2024:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

US Treasury Securities (due in less than
   one year)

 

$

39,855

 

 

$

(30

)

 

$

 

 

$

 

 

$

39,855

 

 

$

(30

)

Government-sponsored enterprise
   securities (due in less than one year)

 

 

30,562

 

 

 

(19

)

 

 

13,928

 

 

 

(25

)

 

 

44,490

 

 

 

(44

)

Government-sponsored enterprise
   securities (due in one to two years)

 

 

4,991

 

 

 

(9

)

 

 

 

 

 

 

 

 

4,991

 

 

 

(9

)

Commercial paper (due in less than
   one year)

 

 

110,209

 

 

 

(192

)

 

 

 

 

 

 

 

 

110,209

 

 

 

(192

)

Corporate notes (due in less than
   one year)

 

 

40,815

 

 

 

(76

)

 

 

10,420

 

 

 

(39

)

 

 

51,235

 

 

 

(115

)

Corporate notes (due in one to
   two years)

 

 

61,514

 

 

 

(121

)

 

 

 

 

 

 

 

 

61,514

 

 

 

(121

)

 

 

$

287,946

 

 

$

(447

)

 

$

24,348

 

 

$

(64

)

 

$

312,294

 

 

$

(511

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2023:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Government-sponsored enterprise
   securities (due in less than one year)

 

$

69,377

 

 

$

(92

)

 

$

 

 

$

 

 

$

69,377

 

 

 

(92

)

Commercial paper (due in less than
   one year)

 

 

58,622

 

 

 

(33

)

 

 

 

 

 

 

 

 

58,622

 

 

 

(33

)

Corporate notes (due in
   less than one year)

 

 

34,567

 

 

 

(63

)

 

 

 

 

 

 

 

 

34,567

 

 

 

(63

)

Corporate notes (due in
   one to two years)

 

 

3,952

 

 

 

(23

)

 

 

 

 

 

 

 

 

3,952

 

 

 

(23

)

 

 

$

166,518

 

 

$

(211

)

 

$

 

 

$

 

 

$

166,518

 

 

$

(211

)

 

Schedule of financial instruments measured at fair value on recurring basis

The following table presents information about our financial instruments that are measured at fair value on a recurring basis as of June 30, 2024 and December 31, 2023 and indicates the fair value category assigned.

 

 

 

Fair Value Measurements at Reporting Date Using

 

 

 

Quoted Prices in

 

 

 

 

 

Significant

 

 

 

 

 

 

Active Markets for

 

 

Significant Other

 

 

Unobservable

 

 

 

 

 

 

Identical Assets

 

 

Observable Inputs

 

 

Inputs

 

 

 

 

(In thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

As of June 30, 2024:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds(1)(2)

 

$

75,651

 

 

$

 

 

$

 

 

$

75,651

 

Certificate of deposit(2)

 

 

273

 

 

 

 

 

 

 

 

 

273

 

U.S. Treasury securities(3)

 

 

 

 

 

39,855

 

 

 

 

 

 

39,855

 

Government-sponsored enterprise
   securities
(3)(4)

 

 

 

 

 

49,481

 

 

 

 

 

 

49,481

 

Commercial paper(3)

 

 

 

 

 

110,209

 

 

 

 

 

 

110,209

 

Corporate notes(3)(4)

 

 

 

 

 

112,748

 

 

 

 

 

 

112,748

 

Total

 

$

75,924

 

 

$

312,293

 

 

$

 

 

$

388,217

 

As of December 31, 2023:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds(1)(2)

 

$

17,658

 

 

$

 

 

$

 

 

$

17,658

 

Certificate of deposit(2)

 

 

272

 

 

 

 

 

 

 

 

 

272

 

U.S. Treasury securities(3)(4)

 

 

 

 

 

29,742

 

 

 

 

 

 

29,742

 

Government-sponsored enterprise
   securities
(3)(4)

 

 

 

 

 

99,872

 

 

 

 

 

 

99,872

 

Commercial paper(3)

 

 

 

 

 

102,268

 

 

 

 

 

 

102,268

 

Corporate notes(3)(4)

 

 

 

 

 

75,092

 

 

 

 

 

 

75,092

 

Total

 

$

17,930

 

 

$

306,974

 

 

$

 

 

$

324,904

 

(1)
Included in cash and cash equivalents on our condensed consolidated balance sheets.
(2)
Included in restricted cash on our condensed consolidated balance sheets.
(3)
Included in current portion of marketable securities on our condensed consolidated balance sheets.
(4)
Included in noncurrent portion of marketable securities on our condensed consolidated balance sheets.